Anhui Fengyuan Pharmaceutical Co Ltd (000153) — Net Asset Quality Index

Latest as of March 2026: 41.0%

Anhui Fengyuan Pharmaceutical Co Ltd (000153) has a Net Asset Quality Index of 41.0% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥5.37 Billion minus total liabilities of CN¥3.17 Billion yields net assets of CN¥2.20 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check financial resilience of Anhui Fengyuan Pharmaceutical Co Ltd to evaluate the company's liquid asset resilience ratio.

Quality Index

41.0%
Equity / Total Assets

Net Assets

CN¥2.20 Billion
CNY

Total Assets

CN¥5.37 Billion
CNY

Total Liabilities

CN¥3.17 Billion
CNY

Anhui Fengyuan Pharmaceutical Co Ltd Net Asset Quality Index Over Time (1997–2025)

This chart shows how Anhui Fengyuan Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 29 annual periods from 1997 to 2025. As of March 2026, the index stands at 41.0%, representing net assets of CN¥2.20 Billion against total assets of CN¥5.37 Billion CNY. See Anhui Fengyuan Pharmaceutical Co Ltd (000153) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Annual Net Asset Quality Index for Anhui Fengyuan Pharmaceutical Co Ltd (1997–2025)

The table below presents the year-by-year Net Asset Quality Index for Anhui Fengyuan Pharmaceutical Co Ltd from 1997 to 2025, covering 29 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 000153 market cap.

Year Quality Index Net Assets (CNY) Total Assets Total Liabilities Change (pp)
2025 42.0% CN¥2.13 Billion CN¥5.06 Billion CN¥2.93 Billion ▼ -1.5 pp
2024 43.5% CN¥2.05 Billion CN¥4.70 Billion CN¥2.65 Billion ▼ -0.2 pp
2023 43.7% CN¥1.92 Billion CN¥4.39 Billion CN¥2.47 Billion ▲ +4.4 pp
2022 39.3% CN¥1.75 Billion CN¥4.47 Billion CN¥2.71 Billion ▼ -1.6 pp
2021 40.8% CN¥1.56 Billion CN¥3.82 Billion CN¥2.26 Billion ▲ +1.0 pp
2020 39.8% CN¥1.45 Billion CN¥3.64 Billion CN¥2.19 Billion ▲ +2.5 pp
2019 37.3% CN¥1.33 Billion CN¥3.56 Billion CN¥2.23 Billion ▼ -5.7 pp
2018 42.9% CN¥1.29 Billion CN¥3.01 Billion CN¥1.72 Billion ▼ -1.2 pp
2017 44.1% CN¥1.22 Billion CN¥2.77 Billion CN¥1.55 Billion ▼ -2.2 pp
2016 46.3% CN¥1.15 Billion CN¥2.49 Billion CN¥1.34 Billion ▼ -5.1 pp
2015 51.4% CN¥1.18 Billion CN¥2.31 Billion CN¥1.12 Billion ▲ +0.1 pp
2014 51.3% CN¥1.15 Billion CN¥2.24 Billion CN¥1.09 Billion ▼ -2.0 pp
2013 53.2% CN¥1.05 Billion CN¥1.98 Billion CN¥926.72 Million ▼ -0.2 pp
2012 53.4% CN¥775.01 Million CN¥1.45 Billion CN¥675.47 Million ▼ -4.6 pp
2011 58.1% CN¥765.24 Million CN¥1.32 Billion CN¥552.99 Million ▼ -1.0 pp
2010 59.1% CN¥753.81 Million CN¥1.28 Billion CN¥522.02 Million ▲ +2.8 pp
2009 56.3% CN¥678.70 Million CN¥1.21 Billion CN¥526.78 Million ▲ +0.2 pp
2008 56.1% CN¥654.09 Million CN¥1.17 Billion CN¥511.47 Million ▼ -2.6 pp
2007 58.7% CN¥638.89 Million CN¥1.09 Billion CN¥449.73 Million ▲ +0.5 pp
2006 58.2% CN¥620.49 Million CN¥1.07 Billion CN¥445.10 Million ▲ +3.4 pp
2005 54.9% CN¥599.59 Million CN¥1.09 Billion CN¥493.08 Million ▼ -11.1 pp
2004 66.0% CN¥591.07 Million CN¥895.92 Million CN¥304.86 Million ▼ -12.2 pp
2003 78.2% CN¥576.00 Million CN¥736.92 Million CN¥160.93 Million ▼ -3.8 pp
2002 81.9% CN¥560.87 Million CN¥684.42 Million CN¥123.55 Million ▲ +6.4 pp
2001 75.6% CN¥536.15 Million CN¥709.48 Million CN¥173.33 Million ▼ -8.3 pp
2000 83.9% CN¥532.50 Million CN¥634.79 Million CN¥102.28 Million ▲ +44.5 pp
1999 39.4% CN¥52.98 Million CN¥134.63 Million CN¥81.65 Million ▼ -0.8 pp
1998 40.2% CN¥44.35 Million CN¥110.33 Million CN¥65.98 Million ▼ -0.6 pp
1997 40.8% CN¥24.03 Million CN¥58.92 Million CN¥34.89 Million
pp = percentage points